Gala Pharmaceuticals Inc., uses proprietary equipment and techniques to ensure the genetic fingerprint of each plant is identical and is cultivated in a controlled environment significantly reducing the variability of each plants yield.
It is anticipated that Gala Pharmaceuticals Inc., will provide oversight for the development of
fully cGMP production of Active Pharmaceutical Ingredients (API) for use in forecasted clinical
trials supporting the safety and efficacy of the various plant extracts.
Gala Pharmaceuticals has industry-leading expertise in the field of Controlled Environment Genetics (CEG) and related technology that improves crop yields by utilizing patent-pending advanced CEG digital 3D cloning techniques to combine top plant varieties with the very best genetics, maximizing the variation of positive inherited characteristics in each plant.
The Gala Pharmaceuticals team uses its experience to help companies make the most of their potential in a complex business world.
The rapidly evolving market of plant genetics and plant genomics is a key part of the growing scientific and economic ecosystem spurred by the advent of high-throughput genome sequencing.
The small flowering mustard plant Arabidopsis thaliana, easy to grow in the laboratory and featuring a relatively small genome (just five chromosomes), was the gold standard for plant research in the 1980s. As a result, in 2000 Arabidopsis was the first plant to be completely sequenced.
Flash forward and in 2016 the global genome editing market reached US$2.84 billion in value and is expected to reach US$5.54 billion by 2021, growing at a CAGR of 14.3%, according to a 2016 report from Markets and Markets titled “Genome Editing/Genome Engineering Market.”
According to the report, the global genome editing market is segmented on the basis of technology, application, end user and region.
Understanding Genetics and Genomics
Genetics — the study of heredity and the variation of inherited characteristic
Genomics — an interdisciplinary field of science and branch of molecular biology focusing on the structure, function, evolution and mapping of genomes – complete sets of DNA within single cells of an organism.
Genomic — related to the complete set of genes or genetic material present in a cell or organism.
Genome — the complete set of genes or genetic material present in a cell or organism.
Genotype — an organism’s complete heritable genetic identity
Phenotype — the set of observable characteristics of an individual resulting from the interaction of its genotype with the environment.
Controlled Environmental Genomics, Inc. (CEG), Akron, Ohio, is a genomics company with expertise in digital plant gene sequencing, editing and cloning technologies.
CEG is a subsidiary of Gala Pharmaceuticals Inc., Irvine, Calif., a publicly-traded development firm specializing in equity investments, debt financing and mergers and acquisitions (M&A) in industries such as agricultural sciences and plant molecular genetics, plant biotechnology and plant breeding.
Gala Pharmaceuticals' professional services group provides operational services and technologies that drive efficiencies in the greenhouse-grown commercial plants and herbs markets.